Origin.Bio secures $15 million funding to help manufacturers create a more sustainable future
Start-up connects bioengineers with nature to hack entirely new organisms, freeing
manufacturers from petrochemical dependency
02-Jun-2021 -
Origin.Bio-- a synthetic biology company that replicates and improves ingredients from traditional chemical industrialisation processes, freeing manufacturers from petrochemical dependency -- today announces a $15m funding round led by EQT Ventures. Existing investor BlueYard Capital also ...
funding
synthetic biology
synthetic microorganisms